Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaine Supplementation for Cardiometabolic Effects in Overweight Subjects with Dysglycemia
NCT01950039Phase 2Completed
- Sponsor
- Joslin Diabetes Center
- Start
- Jan 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prediabetes and obesity comparing Betaine with Placebo (2 arms). Primary endpoints: Fasting Glucose Levels at 12 weeks, 2 Hour Glucose Levels at 12 weeks and 4 more. Started Jan 2014; status: completed.
02
Drugs
betaine
03
Conditions
prediabetesobesity
Beyond the preview
Go deeper on NCT01950039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950039.